Association between enhancer of zeste homolog 2 (EZH2) mRNA/protein, histone deacetylase (HDAC) mRNA/protein, and response to suberoylanilide hydroxamic acid (SAHA) in 12 non‐small cell lung cancer cell lines. Here, EZH2 is linked to lung cancer.